72 Impact of microbiome modulation on serum cytokine profile in a randomized, phase I trial of cabozantinib/nivolumab (cabo/nivo) with or without CBM588 in pts with metastatic renal cell carcinoma (mRCC)
72 在卡博替尼/纳武利尤单抗（cabo/nivo）联合或不联合 CBM588 治疗转移性肾细胞癌 (mRCC) 患者的随机 I 期试验中，微生物组调节对血清细胞因子谱的影响
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.96.6.2615
Recchia, A; Parks, R J; Lamartina, S; Toniatti, C; Pieroni, L; Palombo, F; Ciliberto, G; Graham, F L; Cortese, R; La Monica, N; Colloca, S; Woodward, Jennifer; Smith, Timothy Ryan; Morris, Jill K; Townley, Ryan A; Gillen, Lindsey; Vidoni, Eric D; Mudaranthakam, Dinesh Pal; Parks, Adam; Brunette, Amanda; Niedens, Michelle; Perales‐Puchalt, Jaime; Lewandowski, Tina; Ellis, Shellie; Morrow, Emily; Jones, Janell; Comfort, Branden; Bhattacharya, Shelley; Forcino, Rachel; Bucy, Taylor; Burns, Jeffrey M; Li, Yu Jun; Ebrahimi, Hedyeh; Meza, Luis; Malhotra, Jasnoor; Li, Xiaochen; Dizman, Nazli; Dorff, Tanya; Frankel, Paul; Llamas-Quitiquit, Marian; Hsu, JoAnn; Zengin, Zeynep; Alcantara, Marice; Castro, Daniela; Mercier, Benjamin; Chawla, Neal; Chehrazi-Raffle, Alexander; Barragan-Carrillo, Regina; Gillece, John; Trent, Jeffrey; Lee, Peter; Parks, Thomas; Takahashi, Motomichi; Hayashi, Atsushi; Caporaso, J Gregory; Lee, Keehoon; Tripathi, Abhishek; Pal, Sumanta
